Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy

doi:10.4254/wjh.v15.i11.1226

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1718)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

WORD

HTML

1060

Figures (1-1)

139

Tables (1-4)

143

Sum=1402

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

174

Sum=252

Nov 27, 2023 (publication date) through Jun 16, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Hepatol. Nov 27, 2023; 15(11): 1226-1236
Published online Nov 27, 2023. doi: 10.4254/wjh.v15.i11.1226

Open in New Tab Full Size Figure Download Figure

Figure 1 Consort diagram.

Citation: Ward JA, Yerke J, Lumpkin M, Kapoor A, Lindenmeyer CC, Bass S. Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy. World J Hepatol 2023; 15(11): 1226-1236
URL: https://www.wjgnet.com/1948-5182/full/v15/i11/1226.htm
DOI: https://dx.doi.org/10.4254/wjh.v15.i11.1226